Growth Metrics

Myomo (MYO) EPS (Basic) (2016 - 2025)

Myomo filings provide 9 years of EPS (Basic) readings, the most recent being -$0.09 for Q3 2025.

  • On a quarterly basis, EPS (Basic) fell 200.0% to -$0.09 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.28, a 21.74% decrease, with the full-year FY2024 number at -$0.16, up 42.86% from a year prior.
  • EPS (Basic) hit -$0.09 in Q3 2025 for Myomo, up from -$0.11 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.85 in Q4 2024 to a low of -$0.57 in Q1 2021.
  • Median EPS (Basic) over the past 5 years was -$0.11 (2023), compared with a mean of -$0.17.
  • Biggest five-year swings in EPS (Basic): tumbled 1175.0% in 2021 and later soared 1313.25% in 2024.
  • Myomo's EPS (Basic) stood at -$0.51 in 2021, then surged by 45.1% to -$0.28 in 2022, then surged by 75.0% to -$0.07 in 2023, then soared by 1313.25% to $0.85 in 2024, then crashed by 110.6% to -$0.09 in 2025.
  • The last three reported values for EPS (Basic) were -$0.09 (Q3 2025), -$0.11 (Q2 2025), and -$0.08 (Q1 2025) per Business Quant data.